跳至主要内容
临床试验/JPRN-UMIN000015035
JPRN-UMIN000015035已完成2 期

Examination of the relationship of image on the morphological changes and prognosis by XELOX + bevacizumab therapy in the healing unresectable advanced or recurrent colorectal cancer with liver metastasis - Examination of the relationship of image on the morphological changes and prognosis by XELOX + bevacizumab therapy in the healing unresectable advanced or recurrent colorectal cancer with liver metastasis

Yokohama City University Hospital0 个研究点目标入组 50 人开始时间: 2014年9月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) On the image, brain metastases are found, or from clinical symptoms, brain metastasis is suspected. (2) Cerebrovascular neuropathy, or with a history within one year prior to enrollment. It has been conducted surgery within 4 weeks. (3)Prior to enrollment, biopsy with incision, the suture treatment for trauma, or have implemented fine-needle aspiration cytology within 1 week. (4) Traumatic fracture not healing (5) Bleeding tendency, or to have a coagulopathy. (6)The administration of an anti-thrombotic agent for thrombosis within 10 days before registration (7) Require the administration of aspirin formulation of 325 mg or more. (8) It has with symptoms at the time of registration and the (corresponding to grade 2 or more in Ver.3.0 Japanese translation JCOG / JSCO version NCI-CTCAE) heart disease or are doing some kind of treatment. Alternatively, there is a history of myocardial infarction within one year prior to enrollment. (9) on the image, a body cavity fluid requiring treatment. (10)Digestive cancer carcinoma in situ of the cervix and skin basal cell carcinoma, or by endoscopic mucosal resection endoscopic, healing has been confirmed, transition is not observed overlap cancer of less than five years was (healing disease-free interval it has to a) except for the prostate cancer (11) And has a neuropathy of grade 1 or more Ver.3.0 Japanese translation JCOG / JSCO version NCI-CTCAE (12)Pregnant women, lactating women, pregnancy test positive. Or, patients with no intention to contraception. (13) Oxaliplatin, or with a history of hypersensitivity to severe capecitabine (14) Suspected (DPD) deficiency dihydropyrimidine dehydrogenase, adverse reactions to fluoropyrimidine drugs was expressed. (15)Investigator deems inappropriate to participate in the test (16)The cases with serious complications (uncontrolled digestive ulcer, hypertension, diarrhea, infections, gastrointestinal perforation, such as interstitial pneumonia or pulmonary fibrosis)

研究者

相似试验